To be clear: 100 patients reach the stage of being on a ventilators. Treat 100 with Remestemcel-L and save 31 lives. Plus shorten hospital stays for those who survive. That is what the trial results show. And it's not worth the cost to treat those 100 patients? @Sorepocket, you know very well what the trial says, but you are intentionally misrepresenting it because you have no actual ammunition for your downramping machine gun.
Ann: COVID ARDS Trial Topline 60-Day Results, page-360
-
- There are more pages in this discussion • 1,269 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
-0.030(2.03%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $1.48 | $1.51 | $1.43 | $6.613M | 4.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2482 | $1.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.46 | 27045 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |